Publications

Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: a systematic review and critical analysis

Coagulopathy and thromboembolism are both increased in pregnancies affected by COVID-19 infection.

Authors

Keelin O'Donoghue

Year
2021
Journal Name
BMC Pregnancy and Childbirth
Category
Journal Article
Keywords
COVID-19
Full Citation

Servante J, Swallow G, Thornton JG, Myers B, Munireddy S, Malinowski AK, Othman M, Li W, O'Donoghue K, Walker KF. Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: a systematic review and critical analysis. BMC Pregnancy Childbirth. 2021;21:108. https://doi.org/10.1186/s12884-021-03568-0.

Link to Publication
https://doi.org/10.1186/s12884-021-03568-0

Abstract

A detailed review of published studies on pregnant women with COVID-19 infection was undertaken. The review focussed on studies where women had abnormal blood clotting tests, a blood clotting disorder or evidence of a blood clot in organs, arteries or veins, as a result of COVID-19 infection. Results showed that the risk of a clotting problem or blood clot was increased in pregnant women with COVID-19 infection. In some women this was a sign of serious illness. This review provided evidence that blood thinning medication should be considered  in women at risk of blood clots, with COVID-19 infection an additional new risk factor in pregnancy.

Pregnancy Loss Research Group

Pregnancy Loss Research Group, Department of Obstetrics & Gynaecology, University College Cork, Fifth Floor, Cork University Maternity Hospital, Wilton, Cork, T12 YE02, Ireland,

Top